HomeAI · summaries
Storia in 3 fonti
'We're paranoid.' As China biotech competition heats up, American drugmakers get more secretive
US biotechs turn tight-lipped on gene targets and pipelines as China's fast-follower threat intensifies, 20+ founders and investors tell Endpoints.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
scmp.com
China’s biotech boom: RAS-targeted drugs challenge US dominance
The rapid development of China’s RAS-targeted cancer drugs could reshape global oncology and unlock the country’s undervalued biotech firms.
- ·
infobae.com
Las biotecnológicas de Estados Unidos endurecen el secreto para frenar las copias de China
La nueva cautela limita la difusión de datos sobre ensayos, moléculas y resultados preliminares, tras el avance de la investigación clínica china, que puede duplicar la velocidad…
